Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY
dc.contributor.author | Broome, DT | |
dc.contributor.author | Mehdi, A | |
dc.contributor.author | Chase, C | |
dc.contributor.author | de Freitas, MF | |
dc.contributor.author | Gregg, BE | |
dc.contributor.author | Oral, EA | |
dc.contributor.author | Herman, WH | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2025-01-23T03:38:28Z | |
dc.date.available | 2025-01-23T03:38:28Z | |
dc.date.issued | 2024-09-01 | |
dc.identifier.issn | 0149-5992 | |
dc.identifier.issn | 1935-5548 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/39008714 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/196327 | en |
dc.format.medium | ||
dc.language | eng | |
dc.publisher | American Diabetes Association | |
dc.subject | Adult | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Gastric Inhibitory Polypeptide | |
dc.subject | Hepatocyte Nuclear Factor 1-alpha | |
dc.subject | Hepatocyte Nuclear Factor 4 | |
dc.subject | Receptors, Gastrointestinal Hormone | |
dc.subject | Middle Aged | |
dc.subject | Glucagon-Like Peptide-1 Receptor Agonists | |
dc.title | Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY | |
dc.type | Article | |
dc.identifier.pmid | 39008714 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/196327/2/Use of a Dual GIPGLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.pdf | |
dc.identifier.doi | 10.2337/dc24-0730 | |
dc.identifier.doi | https://dx.doi.org/10.7302/25163 | |
dc.identifier.source | Diabetes Care | |
dc.description.version | Published version | |
dc.date.updated | 2025-01-23T03:38:28Z | |
dc.identifier.orcid | 0000-0002-4964-7716 | |
dc.identifier.orcid | 0000-0003-1943-1575 | |
dc.identifier.orcid | 0000-0002-1192-2997 | |
dc.identifier.orcid | 0000-0001-5761-719X | |
dc.identifier.orcid | 0000-0002-0502-674X | |
dc.description.filedescription | Description of Use of a Dual GIPGLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.pdf : Published version | |
dc.identifier.volume | 47 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | e65 | |
dc.identifier.endpage | e66 | |
dc.identifier.name-orcid | Broome, DT; 0000-0002-4964-7716 | |
dc.identifier.name-orcid | Mehdi, A | |
dc.identifier.name-orcid | Chase, C; 0000-0003-1943-1575 | |
dc.identifier.name-orcid | de Freitas, MF | |
dc.identifier.name-orcid | Gregg, BE; 0000-0002-1192-2997 | |
dc.identifier.name-orcid | Oral, EA; 0000-0001-5761-719X | |
dc.identifier.name-orcid | Herman, WH; 0000-0002-0502-674X | |
dc.working.doi | 10.7302/25163 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.